de.mpg.escidoc.pubman.appbase.FacesBean
English
 
Help Guide Disclaimer Contact us Login
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized double blind trial.

MPS-Authors
http://pubman.mpdl.mpg.de/cone/persons/resource/persons80414

Kümpfel,  T.
Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80504

Rupprecht,  R.
Rainer Rupprecht (Max-Planck Fellow), Max Planck Institute of Psychiatry, Max Planck Society;

http://pubman.mpdl.mpg.de/cone/persons/resource/persons80372

Holsboer,  F.
Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Then Bergh, F., Kümpfel, T., Grasser, A., Rupprecht, R., Holsboer, F., & Trenkwalder, C. (2001). Combined treatment with corticosteroids and moclobemide favors normalization of hypothalamo-pituitary-adrenal axis dysregulation in relapsing-remitting multiple sclerosis: a randomized double blind trial. Journal of Clinical Endocrinology & Metabolism, 86, 1610-1615.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-A316-F
Abstract
There is no abstract available